QA: Sio Gene Therapies Inc in us_pharma/2020

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001636050_2021_Sio_Gene_Therapies_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001636050, Sio Gene Therapies Inc

  xvar xval
0 AssetsCurrent 85,430,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 801,000
3 remainder_Assets 7,449,000
4 LiabilitiesCurrent 32,043,000
5 LiabilitiesNoncurrent 79,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 25,355,378
9 ResearchAndDevelopmentExpense 782,963
10 remainder_Expenses 4,966,093
11 remainder_Revenues 0
12 remainder_NetIncome 3,320,899
13 remainder_ComprehensiveNetIncome 785,000
  yvar yval
0 Assets 93,680,000
1 Liabilities 32,122,000
2 Expenses 31,104,434
3 Revenues 0
4 StockholdersEquity 61,558,000
5 NetIncome -27,783,535
6 ComprehensiveNetIncome -27,391,035
7 BaseVar 80,506,166
8 EconomicCapitalRatiobeforeLimitedLiability 1.70
9 EconomicCapitalRatio 2.82

Edgar->Model Mapping

Feature Distribution

Change over Time